Please assess the completion status of the following clinical trial:

Trial Title: Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female dyspeptic subjects aged ≥18 years with any nationality~* Patients with gastric biopsy-proven H. pylori related chronic gastritis and no other abnormalities in the upper gastrointestinal tract upon endoscopy~* Patients who were naive to treatment for H. pylori infection.~Exclusion Criteria:~* Pregnant or breastfeeding females~* Patients who were previously treated for H. pylori infection~* Patients who received any antibiotics, bismuth or acid-suppressant drugs within the last month

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard triple therapy (Type: ACTIVE_COMPARATOR): Standard triple therapy group received omeprazole 20 mg, amoxicillin 1 g and clarithromycin 500 mg twice daily for 14 days.
- Quadruple therapy group (Type: EXPERIMENTAL): Quadruple therapy group received omeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, and metronidazole 500 mg twice daily after meals for 14 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).